KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Interest Coverage Ratio: 2017-2022

Historic Interest Coverage Ratio for Sarepta Therapeutics (SRPT) over the last 6 years, with Dec 2022 value amounting to -15.97.

  • Sarepta Therapeutics' Interest Coverage Ratio fell 68.52% to -15.97 in Q4 2022 from the same period last year, while for Dec 2022 it was -9.64, marking a year-over-year decrease of 33.40%. This contributed to the annual value of -12.17 for FY2023, which is 20.84% down from last year.
  • Per Sarepta Therapeutics' latest filing, its Interest Coverage Ratio stood at -15.97 for Q4 2022, which was down 79.20% from -8.91 recorded in Q3 2022.
  • In the past 5 years, Sarepta Therapeutics' Interest Coverage Ratio ranged from a high of -1.67 in Q3 2021 and a low of -37.08 during Q2 2019.
  • In the last 3 years, Sarepta Therapeutics' Interest Coverage Ratio had a median value of -9.52 in 2020 and averaged -9.25.
  • In the last 5 years, Sarepta Therapeutics' Interest Coverage Ratio soared by 97.36% in 2018 and then plummeted by 434.17% in 2022.
  • Over the past 5 years, Sarepta Therapeutics' Interest Coverage Ratio (Quarterly) stood at -19.23 in 2018, then plummeted by 42.73% to -27.44 in 2019, then surged by 66.78% to -9.11 in 2020, then declined by 4.00% to -9.48 in 2021, then crashed by 68.52% to -15.97 in 2022.
  • Its Interest Coverage Ratio was -15.97 in Q4 2022, compared to -8.91 in Q3 2022 and -12.45 in Q2 2022.